Stomach Cancer Trial, Recruiting NCT06627634 Sponsor: Aarhus University Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06627634
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age.
  • People who have been diagnosed with a specific type of stomach or gastroesophageal junction (the area where the food pipe meets the stomach) cancer called adenocarcinoma, at various stages, with no more than 30% of the liver affected.
  • People whose primary tumour has been assessed by scans as able to be surgically removed.
  • People who are considered well enough for surgery, based on two standard health scoring systems used by doctors to assess fitness for an operation.
  • People whose cancer has been assessed by their treating doctor as suitable for treatment with a specific chemotherapy combination called FLOT.
  • People who have given their informed consent to participate in the trial.

Who may not be able to join:

  • People whose cancer cannot be surgically removed.
  • People whose cancer has grown directly into nearby organs such as the pancreas, colon, blood vessels, or bones.
  • People who have been diagnosed with or treated for another cancer within the last 2 years, unless it was a low-risk skin cancer (not melanoma).
  • People who have had previous surgery on the food pipe, stomach, or upper small intestine that has changed the normal structure of those areas.
  • People with a Body Mass Index (a measure of body weight relative to height) of 18 or below.
  • People who are unable to understand or read the consent form.
  • People with other serious illnesses or active infections.
  • People who are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Willy Kjaer, MD, PhD, Aarhus University Hospital

Phone: +4520404424

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aarhus University Hospital
Registry
ClinicalTrials.gov
Start date
1 December 2020
Est. completion
1 December 2024

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov